Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Weber

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapyJeffrey Weber, Michael Atkins, Patrick Hwu, et al.
Gastrointestinal Endoscopy|March 31, 2016
Endoscopic management of a gastrocolonic fistulaToufic Kachaamy, Louis M Wong Kee Song, Robert Wascher, et al.
American Journal of Public Health|March 20, 2020
New Systematic Therapies and Trends in Cutaneous Melanoma Deaths Among US Whites, 1986-2016Juliana Berk-Krauss, Jennifer A Stein, Jeffrey Weber, et al.
Plos One|November 30, 2017
A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapyScott Mitchell, John P Williams, Harsimrandeep Bhatti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Characterization of long-term effector-memory T-cell responses in patients with resected high-risk melanoma receiving a melanoma Peptide vaccineBrian Chiong, Raymond Wong, Peter Lee, et al.
Cancer Immunology Research|August 23, 2015
HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 BlockadeDavid M Woods, Andressa L Sodré, Alejandro Villagra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanomaRaymond Wong, Roy Lau, Jenny Chang, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 25, 2020
Risk of Toxicity After Initiating Immune Checkpoint Inhibitor Treatment in Patients With Rheumatoid ArthritisElizaveta Efuni, Samuel Cytryn, Patrick Boland, et al.
Plos Medicine|May 10, 2007
Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanomaRebecca J Critchley-Thorne, Ning Yan, Serban Nacu, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibitionAndressa S Laino, David Woods, Melinda Vassallo, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapyJeffrey Weber, Michael Atkins, Patrick Hwu, et al.
Gastrointestinal Endoscopy|March 31, 2016
Endoscopic management of a gastrocolonic fistulaToufic Kachaamy, Louis M Wong Kee Song, Robert Wascher, et al.
American Journal of Public Health|March 20, 2020
New Systematic Therapies and Trends in Cutaneous Melanoma Deaths Among US Whites, 1986-2016Juliana Berk-Krauss, Jennifer A Stein, Jeffrey Weber, et al.
Plos One|November 30, 2017
A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapyScott Mitchell, John P Williams, Harsimrandeep Bhatti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Characterization of long-term effector-memory T-cell responses in patients with resected high-risk melanoma receiving a melanoma Peptide vaccineBrian Chiong, Raymond Wong, Peter Lee, et al.
Cancer Immunology Research|August 23, 2015
HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 BlockadeDavid M Woods, Andressa L Sodré, Alejandro Villagra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanomaRaymond Wong, Roy Lau, Jenny Chang, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 25, 2020
Risk of Toxicity After Initiating Immune Checkpoint Inhibitor Treatment in Patients With Rheumatoid ArthritisElizaveta Efuni, Samuel Cytryn, Patrick Boland, et al.
Plos Medicine|May 10, 2007
Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanomaRebecca J Critchley-Thorne, Ning Yan, Serban Nacu, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibitionAndressa S Laino, David Woods, Melinda Vassallo, et al.
Pageof 11